Adaptimmune Therapeutics (ADAP) Plans Offering of ADSs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Adaptimmune Therapeutics (ADAP) Plans Offering of ADSs

Adaptimmune Therapeutics (ADAP) Prices 21 Million Offering at $4/ADS

January 22, 2020 8:49 AM EST

Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced the pricing of an underwritten public offering of 21,000,000 of its American Depositary Shares (ADSs) at a price to the public of $4.00 per ADS. In connection with the offering, Adaptimmune... More